newsfilter
← Latest News
Business Wire·

Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes

Initial Program Focus Will Be On Addressing Manufacturing Scale Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf",